Clinical Trials Browser

Phase 2/3 × OTHER × Cognitive Dysfunction × Clear all

NCT05595109 2022-10-26

Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

Phase 2/3 Unknown

Breast Neoplasms, Peripheral Nervous System Diseases, Cognitive Dysfunction, Cardiotoxicity

NCT03047980 2021-11-01

Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome

Phase 2/3 Completed

10 enrolled 11 charts

Sturge-Weber Syndrome, Cognitive Dysfunction